| Product Name | Margetuximab (Anti-ERBB2 / HER2 / CD340) |
|---|---|
| CAS | 1350624-75-7 |
| Storage condition | Margetuximab (Anti-ERBB2 / HER2 / CD340) |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥3600.00 | Visible after login | |
| 5 mg | 3-5days | ¥15500.00 | Visible after login | |
| 10 mg | 3-5days | ¥28500.00 | Visible after login | |
| 50 mg | 3-5days | ¥126000.00 | Visible after login | |
| 100 mg | 3-5days | ¥235000.00 | Visible after login |
| Product Name | Margetuximab (Anti-ERBB2 / HER2 / CD340) |
|---|---|
| CAS | 1350624-75-7 |
| Storage condition | Margetuximab (Anti-ERBB2 / HER2 / CD340) |
Margetuximab (Anti-ERBB2 / HER2 / CD340) is a Fc-domain optimized IgG monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activities. MW: 146.1 KD.